Intended Use : For Laboratory Research Use Only (not for human or veterinary use)
J Dent 94:103310 Li Z, Li S, Wang N, Xue P, Li Y (2020) Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF-kappaB and MAPK pathways via GLP-1R
95% of patients will continue with the diet, regardless
There was no control group, and the methods of symptom assessment were neither adequately described nor validated
Safety Considerations and Contraindications When used under the supervision of qualified professionals, semaglutide is generally considered safe
TABLE 2 List of seized products and identified active substance(s) in the study